Hypoxia-inducible Factor 1α (HIF-1α)-mediated Hypoxia Increases BACE1 Expression and β-Amyloid Generation

Cited by (438)

Items 101–200 of 438

1. Oxygen metabolism abnormality and Alzheimer's disease: An update
   Guangdong Liu, Cui Yang, Xin Wang, Xi Chen, Yan‐Jiang Wang, Weidong Le · 2023 · Redox Biology
2. Reduced BACE1 Activity Enhances Clearance of Myelin Debris and Regeneration of Axons in the Injured Peripheral Nervous System
   Mohamed H. Farah, Baohan Pan, Paul N. Hoffman, Dana V. Ferraris, Takashi Tsukamoto, Thien Nguyen, Philip C. Wong, Donald L. Price, Barbara Stauch Slusher, John Wesley Griffin · 2011 · Journal of Neuroscience
3. The Influence of Chronic Cerebral Hypoperfusion on Cognitive Function and Amyloid β Metabolism in APP Overexpressing Mice
   Mahito Yamada, Masafumi Ihara, Yoko Okamoto, Takakuni Maki, Kazuo Washida, Akihiro Kitamura, Yoshiki Hase, Hidefumi Ito, Keizo Takao, Tsuyoshi Miyakawa et al. · 2011 · PLoS ONE
4. Oxidative Stress and Hypoxia Contribute to Alzheimer's Disease Pathogenesis: Two Sides of the Same Coin
   Michela Guglielmotto, Elena Tamagno, Oliviero Danni · 2009 · The Scientific World JOURNAL
5. Understanding BACE1: essential protease for amyloid-β production in Alzheimer’s disease
   John H. Stockley, Cora O’Neill · 2008 · Cellular and Molecular Life Sciences
6. Antihypertensive Treatments, Cognitive Decline, and Dementia
   Emmanuelle Duron, Olivier Hanon · 2010 · Journal of Alzheimer s Disease
7. Pathological Impacts of Chronic Hypoxia on Alzheimer’s Disease
   Feng Zhang, Long Niu, Song Li, Weidong Le · 2018 · ACS Chemical Neuroscience
8. Noxious Iron–Calcium Connections in Neurodegeneration
   M. Núñez, C. Hidalgo · 2019 · Frontiers in Neuroscience
9. Vascular pathology: Cause or effect in Alzheimer disease?
   Sergio Rius‐Pérez, Ana M. Tormos, Salvador Pérez, Raquel Taléns‐Visconti · 2017 · Neurología (English Edition)
10. Inhibition of PKCδ reduces amyloid-β levels and reverses Alzheimer disease phenotypes
    Ying Du, Yingjun Zhao, Chuan Li, Qiuyang Zheng, Jing Tian, Zhuyi Li, Timothy Y. Huang, Wei Zhang, Huaxi Xu · 2018 · The Journal of Experimental Medicine
11. Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia
    Carvalho, Cristina, Correia, Sónia C., Santos, Renato X., Cardoso, Susana, Moreira, Paula I., Clark, Timothy A., Zhu, Xiongwei, Smith, Mark A., Perry, George · 2009 · Journal of Bioenergetics and Biomembranes
12. β-Secretase: its biology as a therapeutic target in diseases
    Wang, Haibo, Li, Rena, Shen, Yong · 2013 · Trends in Pharmacological Sciences
13. Cell biology, regulation and inhibition of β‐secretase (BACE‐1)
    Clare E. Hunt, Anthony J. Turner · 2009 · FEBS Journal
14. High glucose upregulates BACE1-mediated Aβ production through ROS-dependent HIF-1α and LXRα/ABCA1-regulated lipid raft reorganization in SK-N-MC cells
    Hyun Jik Lee, Jung Min Ryu, Young Hyun Jung, Sei‐Jung Lee, Jeong Yeon Kim, Sang Hun Lee, In Koo Hwang, Je Kyung Seong, Ho Jae Han · 2016 · Scientific Reports
15. Astrocyte dysfunction and neurovascular impairment in neurological disorders: Correlation or causation?
    Heather McConnell, Zhenzhou Li, Randall L. Woltjer, Anusha Mishra · 2019 · Neurochemistry International
16. A Study on the Pathogenesis of Vascular Cognitive Impairment and Dementia: The Chronic Cerebral Hypoperfusion Hypothesis
    Weiwei Yu, Yao Li, Jun Ping Hu, Jun Wu, Yining Huang · 2022 · Journal of Clinical Medicine
17. Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation
    Alessandra Bulbarelli, Elena Lonati, Anna Brambilla, Antonina Orlando, Emanuela Cazzaniga, Fabrizio Piazza, Carlo Ferrarese, Massimo Masserini, Giulio Sancini · 2012 · Molecular and Cellular Neuroscience
18. Role of Hypoxia Inducible Factor-1α in Alzheimer’s Disease
    Yangyang Wang, Zhenting Huang, Minghao Yuan, Jing Feng, Ruo-Lan Cai, Qian Zou, Yinshuang Pu, Shengyuan Wang, Fei Chen, Wenmin Yi et al. · 2021 · Journal of Alzheimer s Disease
19. Quintessential Risk Factors: Their Role in Promoting Cognitive Dysfunction and Alzheimer’s Disease
    Mak Adam Daulatzai · 2012 · Neurochemical Research
20. Iron Chelator-Mediated Alterations in Gene Expression: Identification of Novel Iron-Regulated Molecules That Are Molecular Targets of Hypoxia-Inducible Factor-1α and p53
    Federica Saletta, Yohan Suryo Rahmanto, Egarit Noulsri, Des Raymond Richardson · 2009 · Molecular Pharmacology
21. Patología vascular: ¿causa o efecto en la enfermedad de Alzheimer?
    Sergio Rius‐Pérez, Ana M. Tormos, Salvador Pérez, Raquel Taléns‐Visconti · 2015 · Neurología
22. Gadd153 and NF-κB Crosstalk Regulates 27-Hydroxycholesterol-Induced Increase in BACE1 and β-Amyloid Production in Human Neuroblastoma SH-SY5Y Cells
    Gurdeep Marwarha, Shaneabbas Raza, Jaya R.P. Prasanthi, Othman Ghribi · 2013 · PLoS ONE · Retracted
23. Transcriptional regulation and its misregulation in Alzheimer’s disease
    Xiao‐Fen Chen, Yun‐wu Zhang, Huaxi Xu, Guojun Bu · 2013 · Molecular Brain
24. Mild oxidative stress induces redistribution of BACE1 in non-apoptotic conditions and promotes the amyloidogenic processing of Alzheimer's disease amyloid precursor protein
    Tan, Jiang-Li, Li, Qiao-Xin, Ciccotosto, Giuseppe D., Crouch, Peter John, Culvenor, Janetta Gladys, White, Anthony Robert, Evin, Genevieve · 2013 · PLoS ONE
25. The Role of Hypoxia-Inducible Factor 1 in Mild Cognitive Impairment
    Osigbemhe Iyalomhe, Sabina I. Swierczek, Ngozi Y. Enwerem, Yuanxiu Chen, Monica O. Adedeji, Joanne S. Allard, Oyonumo E. Ntekim, Shereé M. Johnson, Kakra Hughes, Philip Kurian et al. · 2016 · Cellular and Molecular Neurobiology
26. Targeting dynamin-related protein-1 as a potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease
    Jasvinder Singh Bhatti, Satinder Kaur, Jayapriya Mishra, Dibbanti HariKrishnaReddy, Arti Singh, Arubala P. Reddy, Gurjit Kaur Bhatti, P. Hemachandra Reddy · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
27. Signaling effect of amyloid-β42 on the processing of AβPP
    Massimo Tabaton, Xiongwei Zhu, George L. Perry, Mark A. Smith, Luca Giliberto · 2009 · Experimental Neurology
28. Activation of PKR Causes Amyloid ß-Peptide Accumulation via De-Repression of BACE1 Expression
    Gerard ILL‐Raga, Ernest Palomer, Matthew A. Wozniak, Eva Ramos‐Fernández, Mònica Bosch-Morató, Marta Tajes, Francesc Xavier Guix, José Jorge Galán, Jordi Clarimón, Carmen Antúnez et al. · 2011 · PLoS ONE
29. In Silico Docking and In Vitro Approaches towards BACE1 and Cholinesterases Inhibitory Effect of Citrus Flavanones
    Seungeun Lee, Kumju Youn, Gyutae Lim, Jinhyuk Lee, Mira Jun · 2018 · Molecules
30. Hypoxia Inducible Factor-1α binds and activates γ-secretase for Aβ production under hypoxia and cerebral hypoperfusion
    Alexander, Courtney, Li, Thomas, Hattori, Yorito, Chiu, Danica, Frost, Georgia R., Jonas, Lauren, Liu, Chenge, Anderson, Corey J., Wong, Eitan, Park, Laibaik et al. · 2022 · Molecular Psychiatry
31. Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis
    Mattsson, N, Axelsson, M, Haghighi, S, Malmeström, C, Wu, G, Anckarsäter, R, Sankaranarayanan, S, Andreasson, U, Fredrikson, S, Gundersen, A et al. · 2009 · Multiple Sclerosis Journal
32. Vascular endothelial growth factor (VEGF) regulation by hypoxia inducible factor-1 alpha (HIF1A) starts and peaks during endometrial breakdown, not repair, in a mouse menstrual-like model
    Xihua Chen, Jianbing Liu, Bin He, Yunfeng Li, Shuyan Liu, Bin Wu, Shufang Wang, Shucheng Zhang, Xiangbo Xu, Jiedong Wang · 2015 · Human Reproduction
33. Chronic cerebral hypoperfusion-induced impairment of Aβ clearance requires HB-EGF-dependent sequential activation of HIF1α and MMP9
    Anushruti Ashok, Nagendra Kumar, Waseem Raza, Rukmani Pandey, Sanghamitra Bandyopadhyay · 2016 · Neurobiology of Disease
34. Dysregulation of Neuronal Iron Homeostasis as an Alternative Unifying Effect of Mutations Causing Familial Alzheimer’s Disease
    Amanda L. Lumsden, Jack T. Rogers, Shohreh Majd, Morgan Newman, Greg Trevor Sutherland, Giuseppe Verdile, Michael T. Lardelli · 2018 · Frontiers in Neuroscience
35. Ginkgo biloba protects against intermittent hypoxia-induced memory deficits and hippocampal DNA damage in rats
    Basel A. Abdel‐Wahab, Samy M. Abd El-Aziz · 2012 · Phytomedicine
36. Association between atherosclerosis and Alzheimer's disease: A systematic review and meta‐analysis
    Beijia Xie, Xinrui Shi, Yi Xing, Yi Tang · 2020 · Brain and Behavior
37. CHIP stabilizes amyloid precursor protein via proteasomal degradation and p53‐mediated trans‐repression of β‐secretase
    Amir Kumar Singh, Uttam Pati · 2015 · Aging Cell
38. Neuronal human BACE1 knockin induces systemic diabetes in mice
    Plucińska, Kaja, Dekeryte, Ruta, Koss, David, Shearer, Kirsty, Mody, Nimesh, Whitfield, Phillip D., Doherty, Mary K., Mingarelli, Marco, Welch, Andy, Riedel, Gernot et al. · 2016 · Diabetologia
39. Modulation of ABCA1 by an LXR Agonist Reduces Beta-Amyloid Levels and Improves Outcome after Traumatic Brain Injury
    Loane, David J., Washington, Patricia M., Vardanian, Lilit, Pocivavsek, Ana, Hoe, Hyang-Sook, Duff, Karen E., Cernak, Ibolja, Rebeck, G. William, Faden, Alan I., Burns, Mark P. · 2011 · Journal of Neurotrauma
40. Hypertension and Inflammation in Alzheimer's Disease: Close Partners in Disease Development and Progression!
    Lucy Nelson, Paul Gard, Naji Tabet · 2014 · Journal of Alzheimer s Disease
41. Altered structural brain network resulting from white matter injury in obstructive sleep apnea
    Min‐Hee Lee, Chang‐Ho Yun, Areum Min, Yoon Ho Hwang, Seung Ku Lee, Dong Youn Kim, ROBERT JOSEPH THOMAS, Bong Soo Han, Chol Shin · 2019 · SLEEP
42. The BACE1-PSEN-AβPP Regulatory Axis has an Ancient Role in Response to Low Oxygen/Oxidative Stress
    Seyyed Hani Moussavi Nik, Lachlan Wilson, Morgan Newman, Kevin D. Croft, Trevor Anthony Mori, Ian Musgrave, Michael T. Lardelli · 2012 · Journal of Alzheimer s Disease
43. Mutant Presenilin 1 Increases the Expression and Activity of BACE1
    Luca Giliberto, Roberta Borghi, Alessandra Piccini, Rosa Mangerini, Sandro Sorbi, Gabriella Cirmena, Anna Garuti, Bernardino Francesco Ghetti, Fabrizio Tagliavini, Mohamed R. Mughal et al. · 2009 · Journal of Biological Chemistry
44. RAGE Inhibition in Microglia Prevents Ischemia-Dependent Synaptic Dysfunction in an Amyloid-Enriched Environment
    Nicola Origlia, Chiara Criscuolo, Ottavio Arancio, Shushan Yan, Luciano Domenici · 2014 · Journal of Neuroscience
45. sAβPPα is a Potent Endogenous Inhibitor of BACE1
    Peters-Libeu, Clare, Campagna, Jesus, Mitsumori, Michael, Poksay, Karen S., Spilman, Patricia, Sabogal, Alex, Bredesen, Dale E., John, Varghese · 2015 · Journal of Alzheimer's Disease
46. Disturbed sleep and diabetes: A potential nexus of dementia risk
    Calliope Holingue, Alexandra M. V. Wennberg, Slava Berger, Vsevolod Y. Polotsky, Adam P. Spira · 2018 · Metabolism
47. Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer’s Disease
    Tanya Jayne, Morgan Newman, Giuseppe Verdile, Greg Trevor Sutherland, Gerald W Münch, Ian Musgrave, Seyyed Hani Moussavi Nik, Michael T. Lardelli · 2016 · Journal of Alzheimer s Disease
48. The Normal and Pathologic Roles of the Alzheimer's β-secretase, BACE1
    Patty C. Kandalepas, Robert J. Vassar · 2014 · Current Alzheimer Research
49. Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer’s disease
    Charbel Moussa · 2017 · Expert Opinion on Investigational Drugs
50. Impaired migration signaling in the hippocampus following prenatal hypoxia
    M. Hava Golan, Revital Mane, Gabriela Molczadzki, Michal Zuckerman, Vered Kaplan-Louson, Mahmoud Huleihel, Jose Regino Perez-Polo · 2009 · Neuropharmacology
51. Acute hypoxia promote the phosphorylation of tau via ERK pathway
    Hui Fang, Lifeng Zhang, Fantao Meng, Xin Du, Jiang‐Ning Zhou · 2010 · Neuroscience Letters
52. Melatonin and Its Agonist Ramelteon in Alzheimer′s Disease: Possible Therapeutic Value
    Venkatramanujam Srinivasan, Charanjit Kaur, Seithikurippu Ratnas Pandi-Perumal, Gregory M. Brown, Daniel Pedro Cardinali · 2010 · International Journal of Alzheimer s Disease
53. Formononetin Protects Neurons Against Hypoxia-Induced Cytotoxicity Through Upregulation of ADAM10 and sAβPPα
    Miao Sun, Ting Zhou, Liang Zhou, Qiang Chen, Yan Yu, Huan Yang, Kaiyin Zhong, Ximeng Zhang, Feng Xu, Shao‐Qing Cai et al. · 2012 · Journal of Alzheimer s Disease
54. Hypoxia Affects Neprilysin Expression Through Caspase Activation and an APP Intracellular Domain-dependent Mechanism
    Caroline Kerridge, Daria I. Kozlova, Natalia N. Nalivaeva, Anthony J. Turner · 2015 · Frontiers in Neuroscience
55. Emerging biophysical origins and pathogenic implications of amyloid oligomers
    Hanxi Tang, Nicholas Andrikopoulos, Yuhuan Li, Stone Ke, Yunxiang Sun, Feng Ding, Pu Chun Ke · 2025 · Nature Communications
56. Valproic Acid Reduces Neuritic Plaque Formation and Improves Learning Deficits in APP Swe/ PS 1A246E Transgenic Mice via Preventing the Prenatal Hypoxia‐Induced Down‐Regulation of Neprilysin
    Zheng Wang, Xiaojie Zhang, Ting Li, Jia Li, Yu Tang, Weidong Le · 2013 · CNS Neuroscience & Therapeutics
57. Subcortical Vascular Dementia Biomarker Pattern in Mild Cognitive Impairment
    Maria Bjerke, Ulf Andréasson, Sindre Rolstad, Arto Nordlund, KARIN LIND, Henrik Zetterberg, Åke Edman, Kaj Blennow, Anders Wallin · 2009 · Dementia and Geriatric Cognitive Disorders
58. Is sleep disruption a risk factor for Alzheimer's disease?
    Macedo, Arthur Cassa, Balouch, Sara, Tabet, Naji · 2017 · Journal of Alzheimer’s Disease
59. Cerebral hemodynamics of the aging brain: risk of Alzheimer disease and benefit of aerobic exercise
    Takashi Tarumi, Rong Zhang · 2014 · Frontiers in Physiology
60. Self‐reported obstructive sleep apnea, amyloid and tau burden, and Alzheimer's disease time‐dependent progression
    Omonigho M. Bubu, Ogie Queen Umasabor‐Bubu, Arlener D. Turner, Ankit Parekh, Anna E. Mullins, Korey Kam, Madeline K. Birckbichler, Fahad Mukhtar, Alfred K. Mbah, Natasha J. Williams et al. · 2020 · Alzheimer s & Dementia
61. Melatonin reduces hippocampal β-amyloid generation in rats exposed to chronic intermittent hypoxia
    Kwong‐Man Ng, C. Geoffrey Lau, Man‐Lung Fung · 2010 · Brain Research
62. Exploring the Contribution of Estrogen to Amyloid-Beta Regulation: A Novel Multifactorial Computational Modeling Approach
    Thomas J. Anastasio · 2013 · Frontiers in Pharmacology
63. The Potential Role of Hypoxia-Inducible Factor-1 in the Progression and Therapy of Central Nervous System Diseases
    Hongxiu Chen, Di Ma, Feixue Yue, Yajie Qi, Manman Dou, Liuping Cui, Yingqi Xing · 2021 · Current Neuropharmacology
64. BEYOND AMYLOID: The Next Generation of Alzheimer's Disease Therapeutics
    Guy R. Seabrook, William J. Ray, M. S. Shearman, Melanie L. Hutton · 2007 · Molecular Interventions
65. Endothelin receptor antagonists: Potential in Alzheimer's disease
    Jennifer C Palmer, Seth Love · 2010 · Pharmacological Research
66. Friend or foe: Lactate in neurodegenerative diseases
    Mingyu Wang, Yang Zhou, Wenlian Li, Ling‐Qiang Zhu, Dan Liu · 2024 · Ageing Research Reviews
67. Association between Chronic Blood Pressure Changes and Development of Alzheimer's Disease
    Carlos A. Feldstein · 2012 · Journal of Alzheimer s Disease
68. Crosstalk between nitric oxide and hypoxia-inducible factor signaling pathways: an update
    Poyton, Robert, Hendrickson, Marina · 2015 · Research and Reports in Biochemistry
69. Salidroside attenuates hypoxia-induced abnormal processing of amyloid precursor protein by decreasing BACE1 expression in SH-SY5Y cells
    Qing-Yun Li, Hong-Mei Wang, Zhiquan Wang, Jianfang Ma, Jianqing Ding, Sheng-Di Chen · 2010 · Neuroscience Letters
70. Data-driven modeling of Alzheimer Disease pathogenesis
    Thomas J. Anastasio · 2011 · Journal of Theoretical Biology
71. Hyperbaric oxygen therapy alleviates vascular dysfunction and amyloid burden in an Alzheimer’s disease mouse model and in elderly patients
    Ronit Shapira, Amos Gdalyahu, Irit Gottfried, Efrat Sasson, Amir Hadanny, Shai Efrati, Pablo Blinder, Uri Ashery · 2021 · Aging
72. Detrimental Roles of Hypoxia-Inducible Factor-1α in Severe Hypoxic Brain Diseases
    Yoon Kyung Choi · 2024 · International Journal of Molecular Sciences
73. P2Y receptors in Alzheimer's disease
    Laurie Erb, Cao Chen, Deepa Ajit, Gary A. Weisman · 2014 · Biology of the Cell
74. Reduced Vascular Endothelial Growth Factor and Capillary Density in the Occipital Cortex in Dementia with L ewy Bodies
    James Scott Miners, Hayley Moulding, Rohan de Silva, Seth Love · 2014 · Brain Pathology
75. A Functional Mouse Retroposed Gene Rps23r1 Reduces Alzheimer's β-Amyloid Levels and Tau Phosphorylation
    Yun‐wu Zhang, Shijie Liu, Xue Zhang, Wu‐Bo Li, Yaomin Chen, Xiumei Huang, Liangwu Sun, Wenjie Luo, William J. Netzer, Richard Threadgill et al. · 2009 · Neuron
76. Endothelial Progenitor Cells and Vascular Alterations in Alzheimer’s Disease
    Antía Custodia, Alberto Ouro, Daniel Romaus‐Sanjurjo, Juan Manuel Pías Peleteiro, Helga E. de Vries, José Castillo, Tomás Sobrino · 2022 · Frontiers in Aging Neuroscience
77. White Matter Hypoperfusion and Damage in Dementia: Post‐Mortem Assessment
    Seth Love, James Scott Miners · 2014 · Brain Pathology
78. Decreased expression of GGA3 Protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein
    Claudia Santosa, Stefanie Rasche, Adel Barakat, Shayne A. Bellingham, Michael Ho, Jiang‐Li Tan, Andrew Francis Hill, Colin Louis Masters, Catriona McLean, Genevieve M. Evin · 2011 · Neurobiology of Disease
79. Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes
    James Scott Miners, Jennifer C Palmer, Hannah Mary Tayler, Laura E. Palmer, Emma L. Ashby, Patrick G. Kehoe, Seth Love · 2014 · Frontiers in Aging Neuroscience
80. Neurotropin® alleviates hippocampal neuron damage through a HIF ‐1α/ MAPK pathway
    Wenli Fang, De‐Qiang Zhao, Fei Wang, Mei Li, Shengnuo Fan, Wang Liao, Yuqiu Zheng, Shao‐Wei Liao, Songhua Xiao, Ping Luan et al. · 2017 · CNS Neuroscience & Therapeutics
81. Plasma microRNA vary in association with the progression of Alzheimer's disease
    Diane Guévremont, Helen Tsui, Robert G. Knight, Christopher James Fowler, Colin Louis Masters, Ralph Nigel Martins, Wickliffe C. Abraham, Warren Perry Tate, Nicholas J. Cutfield, Joanna M. Williams · 2022 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
82. Magnesium-L-threonate exhibited a neuroprotective effect against oxidative stress damage in HT22 cells and Alzheimer’s disease mouse model
    Ying Xiong, Yu-Ting Ruan, Jing Zhao, Yuwen Yang, Liping Chen, Yingren Mai, Qun Yu, Zhiyu Cao, Feifei Liu, Wang Liao et al. · 2022 · World Journal of Psychiatry
83. Transcriptional and post‐transcriptional regulation of β‐secretase
    Tamagno, Elena, Guglielmotto, M., Monteleone, D., Vercelli, A., Tabaton, M. · 2012 · IUBMB Life
84. Optical imaging in an Alzheimer’s mouse model reveals amyloid-β-dependent vascular impairment
    Alexander J. Lin, Gangjun Liu, Nicholas A. Castello, James J. Yeh, Rombod Rahimian, Grace Lee, Victoria Tsay, Anthony J. Durkin, Bernard Choi, Frank M. LaFerla et al. · 2014 · Neurophotonics
85. The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders
    W K Jo, Andrew Chi Kin Law, S. K. Chung · 2014 · Molecular Psychiatry
86. HIF-1α Causes LCMT1/PP2A Deficiency and Mediates Tau Hyperphosphorylation and Cognitive Dysfunction during Chronic Hypoxia
    Lei Ling, Jun Feng, Gang Wu, Zhen Cheng Wei, Jian‐Zhi Wang, Bin Zhang, Rong Liu, Fei Liu, Xiaochuan Wang, Honglian Li · 2022 · International Journal of Molecular Sciences
87. Genetic Inhibition of Phosphorylation of the Translation Initiation Factor eIF2α Does Not Block Aβ-Dependent Elevation of BACE1 and APP Levels or Reduce Amyloid Pathology in a Mouse Model of Alzheimer’s Disease
    Katherine R. Sadleir, William A. Eimer, Randal J. Kaufman, Pavel Osten, Robert J. Vassar · 2014 · PLoS ONE
88. Oxidative Stress in the Pathogenesis of Alzheimer's Disease and Cerebrovascular Disease with Therapeutic Implications
    Anamaria Jurcău, Aurel Simion · 2020 · CNS & Neurological Disorders - Drug Targets
89. A Network Pharmacology Approach to Estimate Potential Targets of the Active Ingredients of Epimedium for Alleviating Mild Cognitive Impairment and Treating Alzheimer’s Disease
    Xianwei Gao, Shengnan Li, Chao Cong, Yuejiao Wang, Lianwei Xu · 2021 · Evidence-based Complementary and Alternative Medicine
90. Inhibitory Effect of Ethanol Extract of Magnolia officinalis on Memory Impairment and Amyloidogenesis in a Transgenic Mouse Model of Alzheimer's Disease via Regulating β‐Secretase Activity
    Young‐Jung Lee, Dong‐Young Choi, Sang‐Bae Han, Young Hee Kim, Ki Ho Kim, Bang Yeon Hwang, Jong‐Koo Kang, Beom Jun Lee, Ki-Won Oh, Jin Tae Hong · 2012 · Phytotherapy Research
91. Linking vascular disorders and Alzheimer's disease: Potential involvement of BACE1
    Sarah L. Cole, Robert J. Vassar · 2008 · Neurobiology of Aging
92. Cerebrovascular Hemodynamics on Transcranial Doppler Ultrasonography and Cognitive Decline in Mild Cognitive Impairment
    Eun Ye Lim, Dong‐Won Yang, A-Hyun Cho, Yong Soo Shim · 2018 · Journal of Alzheimer s Disease
93. Modelling Sporadic Alzheimer’s Disease Using Induced Pluripotent Stem Cells
    Helen A. Rowland, Nigel M. Hooper, Katherine A. B. Kellett · 2018 · Neurochemical Research
94. Implications of FBXW7 in Neurodevelopment and Neurodegeneration: Molecular Mechanisms and Therapeutic Potential
    Yu Yang, Xuan Zhou, Xinpeng Liu, Ruying Song, Yiming Gao, Shuai Wang · 2021 · Frontiers in Cellular Neuroscience
95. Neurobiology of Vascular Dementia
    Ana‐Maria Enciu, Stefan N. Constantinescu, Laurentiu Mircea Popescu, Dafin Fior Muresanu, Bogdan Ovidiu Popescu · 2011 · Journal of Aging Research
96. The zebrafish orthologue of familial Alzheimer’s disease gene PRESENILIN 2 is required for normal adult melanotic skin pigmentation
    Haowei Jiang, Morgan Newman, Michael T. Lardelli · 2018 · PLoS ONE
97. Cognition effectiveness of continuous positive airway pressure treatment in obstructive sleep apnea syndrome patients with cognitive impairment: a meta-analysis
    Xinzhao Grace Jiang, Zicong Wang, Nan Hu, Ying Yang, Rui Xiong, Zhengqi Fu · 2021 · Experimental Brain Research
98. Brain‐Penetrating and Disease Site‐Targeting Manganese Dioxide‐Polymer‐Lipid Hybrid Nanoparticles Remodel Microenvironment of Alzheimer's Disease by Regulating Multiple Pathological Pathways
    Elliya Park, Lily Yi Li, Chunsheng He, Azhar Zahoor Abbasi, Taksim Ahmed, Warren D. Foltz, R. Michael O'Flaherty, Maham Zain, Robert P. Bonin, Andrew Michael Rauth et al. · 2023 · Advanced Science
99. Deficiency of the Copper Chaperone for Superoxide Dismutase Increases Amyloid-β Production
    Emma H. Gray, Kurt J. De Vos, Colin Dingwall, Michael S. Perkinton, Christopher C.J. Miller · 2010 · Journal of Alzheimer s Disease
100. Predictors of the Progression of Dementia Severity in Brazilian Patients with Alzheimer's Disease and Vascular Dementia
     Márcia Lorena Fagundes Chaves, Ana Luiza Camozzato, Cristiano André Köhler, Jeffrey Alan Kaye · 2010 · International Journal of Alzheimer s Disease